Neglected Disease Research and Development Funding Analysis

Neglected disease research and development funding data addresses a critical information gap for global health investors. The dataset, authored by M. Susan Moran, likely tracks financial investments in pharmaceutical tools for diseases like HIV/AIDS, tuberculosis, leishmaniasis, and sleeping sickness. It supports analysis aligned with the United Nations Millennium Development Goals for improving health in the developing world.

Use Cases

• Analyze funding trends for neglected disease research based on the description's focus on pharmaceutical tools.
• Model resource allocation for HIV/AIDS vaccine development based on the mentioned health priorities.
• Benchmark investment in diagnostics for tuberculosis (TB) against other disease areas.
• Assess financial flows for treatments targeting leishmaniasis and sleeping sickness.

Strengths

• Focuses on a specific, high-impact domain: funding for neglected diseases like HIV/AIDS, tuberculosis, leishmaniasis, and sleeping sickness.
• Addresses a recognized information gap for funders, as stated in the description.
• Authored by a named individual (M. Susan Moran), providing a point of accountability.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Last update date is unknown; freshness unverified.

Provenance

Source

M. Susan Moran

Collection Method

Method of data gathering is unknown.

Time Range

Temporal coverage is unknown.

Freshness

Last updated date is unknown.

Geography

Spatial coverage is unknown, but the context suggests a global or developing-world focus.